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In this issue of Immunity, Witherden et al. (2012) demonstrate a crucial role for CD100-plexin B2 interactions
in the wound healing response mediated by murine gd T cells and in the T cell morphological changes asso-
ciated with this process.Like sailors, who need landmarks and
lights to take the right direction, devel-
oping neurons and vessels need guiding
cues to indicate where they should
grow, branch, or terminate. Semaphorins,
a large family of secreted or transmem-
brane proteins that share a conserved
‘‘Sema’’ domain, fulfill this guiding role
by providing chemorepellent or chemoat-
tractive signals upon interaction with
plexin receptors. Such signals, which are
associated with major changes in actin
cytoskeleton, regulate axonal pathfinding
and vascular remolding (Kruger et al.,
2005). A role for semaphorins in immune
cell regulation is also supported by
several studies. However whether these
molecules modulate immune cell motility
and morphology, as they do in the neu-
ronal or cardiovascular systems, remains
unclear (Suzuki et al., 2008). In this issue
of Immunity, Witherden et al. (2012)
show a key contribution of the CD100
(Sema4D) semaphorin and its plexin B2
receptor to activation of a murine skin-
resident gd T cell subset in response to
tissue damage. What’s more, the gd
T cell morphological changes that pre-
cede cutaneous wound healing are as-
sociated with activation of key actin re-
gulators in response to CD100 ligation.
Besides providing molecular insights into
the immune control of epithelial homeo-
stasis, this study highlights new parallels
between neural and vascular develop-
ment and immune cell activation. It also
indicates that semaphorins can act not
only as ligands for plexin receptors but
also as direct signaling receptors to exert
their biological functions.
T cell roles have long been restricted to
fighting infections and controlling tumors.194 Immunity 37, August 24, 2012 ª2012 ElsTheir broader implication in the maintai-
nance of body barrier integrity has been
recognized a few decades ago only,
soon after the discovery of a T cell subset
expressing a new type of T cell antigen
recognition receptor (TCR), made of g
and d subunits. gd T cells are well suited
to perform tissue immunosurveillance,
thanks to three salient features. Many of
them reside in tissues, where they ex-
press a diverse array of TCR and non-
TCR molecules specific for conserved
stress-induced ligands. Tissue-resident
gd T cells also display a preactivated
status that allows their swift activation in
response to tissue damage. Moreover,
their varied effector functions endow
them with anti-infectious, antitumor, and
epithelial growth-promoting properties
(Hayday, 2009).
The prototypical and perhaps best-
studied intraepithelial gd T cell subset in
rodents is located in the basal layer of
the epidermis. Skin gd T cells make
multiple and permanent contacts with
surrounding keratinocytes and Langer-
hans cells, through cellular protrusions
(or ‘‘dendrites’’) that confer them a typi-
cal star-like shape. After local infection,
keratinocyte transformation, or epithelial
barrier disruption, dendritic epidermal gd
T cells (DETCs) retract their dendrites
and adopt a rounded shape. Then they
release effector molecules that will clear
pathogens or altered cells, recruit spe-
cialized immune cells at the damaged
site, and promote epithelial regeneration
(Figure 1). DETC deficiency is associated
with increased keratinocyte apoptosis,
impaired wound healing, and enhanced
susceptibility to carcinogenesis, cuta-
neous infections, and dermatitis, thusevier Inc.highlighting the crucial role played by
this T cell subset in maintaining epithelial
integrity (Macleod and Havran, 2011).
Several molecular actors regulate the
complex interplays between DETCs and
nearby cells. DETCs express a unique
canonical TCR made of invariant Vg5
and Vd1 TCR chains, which is specific
for yet ill-defined antigens upregulated
on stressed keratinocytes. Enhanced
TCR signaling in response to keratinocyte
damage triggers DETC effector functions
in vitro. However, in vivo TCR ligation,
e.g., by means of antibodies, does not
induce the DETC morphological changes
associatedwith their full-blown activation,
which suggests implication of additional
receptors (Macleod and Havran, 2011).
NKG2D, a receptor specific for ligands
upregulated on transformed or damaged
keratinocytes, is a major player of DETC-
mediated immunosurveillance. Neverthe-
less, whereasNKG2D triggers or costimu-
lates DETC inflammatory and antitumor
responses, its impact on DETC rounding
remains unclear (Macleod and Havran,
2011).
In this issue, Witherden et al. (2012) de-
scribe a receptor-ligand pair that is crucial
for activation of DETCs in response to
overt skin perturbation. Through func-
tional screening of antibodies generated
against keratinocytes, they identify plexin
B2 as a player implicated in DETC re-
sponse to keratinocytes. In line with pre-
vious evidence for interactions between
plexin B receptors and the CD100 sema-
phorin (Kruger et al., 2005), plexin B2
exerts its effects on DETC activation
through interaction with CD100. Unlike
gd T cell-deficient mice, CD100-defi-
















Figure 1. Contribution of CD100-Plexin B2 Interactions to the SkinWoundHealing Response
Mediated by DETCs
DETC develop dendrites that establish intimate contacts with keratinocytes at steady state. Upregulation
of plexin B2, gd TCR antigens (Ag), and cocksackie adenovirus receptors (CARs) on damaged keratino-
cytes triggers DETC activation through signaling by CD100, Vg5Vd1 TCR, and the junctional adhesion
molecule-like (JAML) costimulator, respectively. CD100 ligation upregulates extracellular regulated
kinases (ERKs) and cofilin, leading to dendrite retraction and DETC rounding. JAML could contribute to
cofilin activation through recruitment of phosphatidyl inositol 3 kinase (PI3K), on the basis of previous
implication of PI3K in cofilin dephosphorylation. After rounding, DETC release epithelial trophic factors
like KGF-1 and KGF-2, whichwill induce keratinocyte proliferation andmigration and restoration of epithe-
lium integrity. In agreement with a key role played by CD100-plexin B2 interactions in DETC rounding that
precedes their full activation, this process is blocked by plexin B2-specific antibodies and in CD100-defi-
cient mice (Witherden et al., 2012). Engagement of plexin B2 by CD100 might also regulate keratinocyte
cytoskeleton andmigration and contribute to dendrite retraction, on the basis of the known signaling prop-
erties of plexin B receptors in nonimmune systems (Kruger et al., 2005).
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of implication of CD100 in the DETC-
mediated maintainance of keratinocyte
homeostasis at the steady state. By
contrast, CD100 and gd T cell-deficient
animals show similarly delayed closure of
cutaneous wounds, consistent with a crit-
ical role played by CD100-plexin B2 inter-
actions in the wound healing response
mediated by DETCs.
Plexin-semaphorin interactions regu-
late axon guidance, cardiac morphogen-
esis and vascular formation, primarily
through modulation of cell morphology
and motility. These changes involve regu-
lation of integrins and actin cytoskeleton
dynamics after signaling through plexin
receptors (Kruger et al., 2005). Sema-
phorin interactions with plexin and non-
plexin receptors also modulate antibody
responses, T cell priming, dendritic cell
maturation, or macrophage activation.
However, most of these immune effects
result from enhanced functional activa-
tion, with limited evidence for regulation
of cell shape or motility (Suzuki et al.,
2008). In this respect, Witherden et al.
(2012) provide strong in vivo evidence
that CD100-plexin B2 interactions are
crucial for DETC rounding in response to
wounding. Moreover, DETC rounding in-duced by in vitro CD100 ligation is associ-
ated with extracellular regulated kinase
(ERK) signaling and cofilin dephosphory-
lation and activation (Figure 1). Cofilin is
an actin-severing molecule that regulates
actin dynamics driving B and T cell
motility, B cell receptor microcluster for-
mation, and T cell amoeboid migration
within tissues (Klemke et al., 2010). There-
fore, activation of the ERK-cofilin module
by CD100 is likely to have a major impact
on DETC morphology and tissue posi-
tioning, although a direct causal rela-
tionship between cofilin activation and
DETC rounding and migration is not
established by Witherden et al. (2012).
Although these observations are reminis-
cent of the morphological changes in-
duced by semaphorin-plexin interactions
in neural and vascular systems, regulation
of actin cytoskeleton in the latter situa-
tions are in most instances induced after
plexin, not semaphorin, signaling (Kruger
et al., 2005). Reverse signaling by sema-
phorins has been suspected, particularly
for type 4 semaphorins like CD100 (Elha-
bazi et al., 1997), and could play an
important role at immune and neural
synapses. However, the downstream sig-
naling events following semaphorin liga-
tion have remained poorly defined, andImmunity 37formal evidence that such reverse sig-
naling can be induced after ligation by
plexins has not been obtained yet. In this
regard, the ability of CD100 to directly
impact on cytoskeleton dynamics through
ERK and cofilin activation provides in-
sights into the downstream events asso-
ciated with semaphorin reverse signaling
and strengthens the overall physiological
relevance of this phenomenon.
Nonetheless, this study leaves open
several burning questions. In particular,
what impact has plexin B2 engagement
on keratinocyte motility and migration?
On the basis of the signaling properties
of plexin B receptors reported in other
systems, it is likely that the bidirectional
crosstalk between CD100 and plexin B2
will regulatemorphological events associ-
ated with the healing process at both the
DETC and keratinocyte sides. In partic-
ular, by analogy with neural cells, plexin
B2 signaling could not only regulate
keratinocyte cytoskeleton and migration,
but also generate chemorepellent signals
and contribute to dendrite retraction.
Moreover, in most nonimmune cellular
systems, the primary signaling receptor
for CD100 is plexin B1, not plexin B2
(Kruger et al., 2005). Because both re-
ceptors are expressed by keratinocytes,
why is the plexin B1-CD100 interaction
not implicated in DETC activation? Is it
due to distinct segregation of plexin B1
and B2 with stress-associated molecules
sensed by DETCs, to differential upregu-
lation of these receptors in response to
keratinocyte damage, or to differences
of CD100 binding affinities?
Contribution of other DETC activating
receptors to DETC rounding is another
important issue that could deserve further
investigations. Whereas CD100 ligation
induces DETC rounding in vitro, this
effect remains suboptimal and probably
requires concurrent TCR engagement,
as suggested by the synergistic effect of
CD100 and TCR ligation on this phenom-
enon (Witherden et al., 2012). Activation of
DETCs in response to wounding also
involves a junctional adhesion molecule,
JAML, that is engaged by cocksackie
and adenovirus receptors (CARs) upregu-
lated on damaged keratinocytes (Wither-
den et al., 2010). Signals induced by
JAML-CAR interactions involve recruit-
ment of phosphatidyl inositol 3 kinase
and Akt phosphorylation. Interestingly, a
similar signaling pathway is triggered by, August 24, 2012 ª2012 Elsevier Inc. 195
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ceptors and is associated with cofilin
dephosphorylation and activation (Sam-
stag et al., 1992). Therefore, one would
expect synergistic effects of CD100 and
JAML engagment on DETC rounding.
Irrespective of these issues, the fact
the plexin B2 is broadly expressed by
several other epithelial tissues where
resident CD100-expressing gd T cells
are located suggest a more general role
for CD100-plexin B2 interactions in the
immune control of epithelial barrier integ-
rity. Moreover, because a CD100 ortholog
is expressed by human T cells and can
modulate their effector functions (Elha-
bazi et al., 1997), semaphorin-plexin inter-196 Immunity 37, August 24, 2012 ª2012 Elsactions could similarly impact on T cell-
epithelial cell crosstalks that have been
recently evidenced in this species (Toulon
et al., 2009).REFERENCES
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Our molecular understanding of how immune cells protect epithelial cells against damage is limited. In this
issue of Immunity, Hanash et al. (2012) report that interleukin-22 produced by innate lymphoid cells provides
protection to the stem cell niche of the intestinal epithelium.Infections and infection-induced immu-
nity are often associated with collateral
damage to tissues, thereby necessitating
tissue repair. At epithelial surfaces, tissue
damage may occur frequently during
steady state due to the continuous
presence of bacteria and noxious com-
pounds. Therefore, it has been proposed
that immune cells contribute to the
protection of epithelial surfaces by
releasing factors that fortify the epithelial
barrier and promote tissue repair. How-
ever, the cell types and molecular
networks involved are poorly understood.
It is widely believed that innate or innate-
like lymphocytes at mucosal barriers
may be central regulators of such pro-
cesses. Lymphocytes located within the
epithelium (intraepithelial lymphocytes
[IELs]), in particular, the intestinal epithe-lium and the skin, were the first to be
characterized as having a regulatory
role (Jameson and Havran, 2007). For
instance, IEL residing in the epidermis of
the skin (i.e., dendritic epidermal gd
T cells) release growth factors (i.e., kerati-
nocyte growth factor, insulin-like growth
factor-1) involved in wound healing and
tissue repair.
Recently, additional subsets of innate
lymphocytes have been discovered that
are now widely referred to as innate
lymphoid cells (ILCs) (Spits and Di Santo,
2011). Numerous ILCs can be found at
mucosal surfaces, and they have added
an important facet to our understanding
of how hematopoietic cells influence
homeostasis and repair of epithelial and
mesenchymal cell types (Sanos et al.,
2011). For example, depletion of type 2ILC (ILC2) in the context of influenza infec-
tion leads to a loss of airway epithelial
integrity and impaired tissue remodeling
(Monticelli et al., 2011). The tissue-protec-
tive effect of ILC2 is at least in part medi-
ated by their production of amphiregulin,
a member of the epidermal growth factor
family that promotes repair of epithelial
cells. Another group of ILCs is develop-
mentally dependent on the transcrip-
tion factor RORgt, which they also con-
tinuously express (Spits and Di Santo,
2011). They are now generally referred to
as RORgt+ ILCs. Subsets of RORgt+
ILCs have lymphoid-tissue-inducing func-
tions, and RORgt+ ILCs are strictly
required for the formation of prenatally
developing lymph nodes and Peyer’s
patches. They are also indispensible in
the organogenesis of multiple postnatally
